Vontobel Holding
EW icon

Vontobel Holding’s Edwards Lifesciences EW Stock Holding History

Vontobel Holding’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2M Sell
245,521
-110,652
-31% -$9.27M 0.07% 220
2026
Q1 		$28.5M Sell
356,173
-1,216
-0.3% -$100K 0.1% 175
2025
Q4 		$30.5M Sell
357,389
-19,365
-5% -$1.59M 0.1% 175
2025
Q3 		$29.3M Sell
376,754
-2,902
-0.8% -$227K 0.09% 157
2025
Q2 		$29.7M Sell
379,656
-5,316
-1% -$396K 0.09% 156
2025
Q1 		$27.9M Sell
384,972
-14,903
-4% -$1.07M 0.1% 140
2024
Q4 		$29.6M Sell
399,875
-39,231
-9% -$2.75M 0.1% 131
2024
Q3 		$29M Buy
439,106
+23,560
+6% +$1.71M 0.09% 139
2024
Q2 		$38.4M Sell
415,546
-13,108
-3% -$1.16M 0.12% 112
2024
Q1 		$41M Buy
428,654
+30,230
+8% +$2.54M 0.33% 83
2023
Q4 		$30.4M Sell
398,424
-17,175
-4% -$1.2M 0.25% 100
2023
Q3 		$28.8M Sell
415,599
-4,424
-1% -$356K 0.27% 96
2023
Q2 		$39.6M Buy
420,023
+28,537
+7% +$2.48M 0.35% 75
2023
Q1 		$32.4M Sell
391,486
-31,006
-7% -$2.44M 0.3% 90
2022
Q4 		$30.9M Buy
422,492
+102,822
+32% +$7.92M 0.31% 84
2022
Q3 		$26.8M Sell
319,670
-7,395
-2% -$712K 0.31% 85
2022
Q2 		$31.4M Buy
327,065
+10,775
+3% +$1.12M 0.34% 70
2022
Q1 		$37M Buy
316,290
+3,784
+1% +$424K 0.32% 66
2021
Q4 		$40.8M Buy
312,506
+50,694
+19% +$5.91M 0.34% 65
2021
Q3 		$29.6M Buy
261,812
+18,812
+8% +$2.15M 0.26% 84
2021
Q2 		$25.2M Buy
243,000
+40,823
+20% +$3.85M 0.22% 99
2021
Q1 		$16.9M Buy
202,177
+3,752
+2% +$317K 0.13% 120
2020
Q4 		$17.1M Buy
+198,425
New +$16.5M 0.11% 124

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Vontobel Holding's EW Position: Q2 2026 in Review

Vontobel Holding reduced its Edwards Lifesciences (EW) stake by 31% in Q2 2026, selling an estimated $9.27M and leaving 245,521 shares worth $22.2M. The position accounts for 0.07% of the portfolio, ranked #220.

Vontobel Holding first reported a position in EW in Q4 2020 and has held it in 23 quarters since. The position peaked at $41M in Q1 2024. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Vontobel Holding held 245,521 shares of Edwards Lifesciences worth $22.2M as of Q2 2026.
  • Vontobel Holding sold 110,652 Edwards Lifesciences shares in Q2 2026, an estimated $9.27M.
  • Edwards Lifesciences made up 0.07% of Vontobel Holding's portfolio in Q2 2026, its #220 holding.
  • Vontobel Holding first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Edwards Lifesciences position peaked at $41M in Q1 2024.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.